BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/21/2016 9:23:00 AM | Browse: 586 | Download: 604
Publication Name World Journal of Hepatology
Manuscript ID 21223
Country/Territory United States
2015-07-01 08:34
Peer-Review Started
2015-07-04 22:33
To Make the First Decision
2015-08-31 16:36
Return for Revision
2015-09-01 11:48
2015-09-12 00:17
Second Decision
2015-12-23 16:36
Accepted by Journal Editor-in-Chief
2015-12-24 08:50
Accepted by Company Editor-in-Chief
2016-01-07 16:34
Articles in Press
2016-01-07 16:34
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-01-10 18:01
Publish the Manuscript Online
2016-01-21 09:23
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Transplantation
Manuscript Type Review
Article Title Management of immunosuppressant agents following liver transplantation: Less is more
Manuscript Source Invited Manuscript
All Author List Mustafa S Ascha, Mona L Ascha and Ibrahim A Hanouneh
Funding Agency and Grant Number
Corresponding author Ibrahim A Hanouneh, MD, Department of Gastroenterology and Hepatology, Digestive Disease Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, United States. hanouni2@ccf.org
Keywords Immunosuppression; Orthotopic liver transplantation; Metabolic syndrome; Acute cellular rejection; Hepatitis C virus
Core Tip The use of immunosuppressive agents is reviewed in the context of the modern post-orthotopic liver transplantation population. The side effects of mainstay immunosuppressive strategies exacerbate some patient pathologies, and combinations of different immunosuppressants could be more specifically tailored to patient needs. Acute cellular rejection and malignant complications are also discussed with respect to im-munosuppressive strategies. Finally, hepatitis C virus and its impact on immunosuppression is re-evaluated in light of recent developments in viral clearance.
Publish Date 2016-01-21 09:23
Citation Ascha MS, Ascha ML, Hanouneh IA. Management of immuno­suppressant agents following liver transplantation: Less is more. World J Hepatol 2016; 8(3): 148-161
Url http://www.wjgnet.com/1948-5182/full/v8/i3/148.htm
DOI http://dx.doi.org/10.4254/wjh.v8.i3.148
Full Article (PDF) WJH-8-148.pdf
Full Article (Word) WJH-8-148.doc
Manuscript File 21223-Review.docx
Answering Reviewers 21223-Answering reviewers.pdf
Audio Core Tip 21223-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 21223-Conflict-of-interest statement.pdf
Copyright License Agreement 21223-Copyright assignment.pdf
Peer-review Report 21223-Peer-review(s).pdf
Journal Editor-in-Chief Review Report 21223-Journal editor-in-chief review report.pdf
Scientific Misconduct Check 21223-Scientific misconduct check.pdf
Scientific Editor Work List 21223-Scientific editor work list.pdf